5 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... Insulin Lifestyle ... Improved outcomes in CKD ... #comparison #management
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... evidence-based pharmacologic ... #Diabetes #CKD # ... #Insulin #metformin ... #ACEi #ARB.
SNRls (Serotonin/Norepinephrine Reuptake Inhibitors) - FDA Approved Indications 

Venlafaxine (Effexor) - GAD, MDD, Panic Disorder, SAD
Inhibitors) - FDA ... Cymbalta) - GAD, MDD, Diabetic ... purpose of these medications ... #Pharmacology # ... Psychiatry #FDA
Pheochromocytoma - Diagnosis and Management Summary
10 percent rule = 10% of pheochromocytomas are extra-adrenal, multiple, bilateral,
Summary 10 percent ... sedimentation rate, insulin ... leukocytosis, psychiatric ... carbohydrate metabolism (insulin ... apparent type 2 diabetes
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... Insulin dependent ... ACEi/ARBs - Hold ... Diabetes regimen ... medical and surgical management